Pub Date : 2024-05-15eCollection Date: 2024-01-01DOI: 10.2144/fsoa-2023-0255
Chintalapati Manogna, Thirumal Margesan
Aim: The aim of this research is to investigate the potential of glucomoringin, derived from Moringa oleifera, as a therapeutic agent for Alzheimer's disease through in silico analysis. Materials & methods: This study employs in silico or computational methodologies, including pkCSM, Swiss ADME, OSIRIS® property explorer, PASS online web resource and MOLINSPIRATION® software, to predict the pharmacokinetic characteristics and biological activity of glucomoringin. Results & conclusion: Molecular docking indicates strong binding to I-1β and the pharmacokinetic profile shows cytochrome P450 enzyme inhibition, prompting further research for dosing strategies. Toxicological predictions affirm safety, while bioactivity assessments demonstrate versatility in modulating essential pathways. glucomoringin's potential for Alzheimer's treatment, emphasizing the need for additional empirical research.
{"title":"<i>In silico</i> and pharmacokinetic studies of glucomoringin from <i>Moringa oleifera</i> root for Alzheimer's disease like pathology.","authors":"Chintalapati Manogna, Thirumal Margesan","doi":"10.2144/fsoa-2023-0255","DOIUrl":"10.2144/fsoa-2023-0255","url":null,"abstract":"<p><p><b>Aim:</b> The aim of this research is to investigate the potential of glucomoringin, derived from <i>Moringa oleifera</i>, as a therapeutic agent for Alzheimer's disease through <i>in silico</i> analysis. <b>Materials & methods:</b> This study employs <i>in silico</i> or computational methodologies, including pkCSM, Swiss ADME, OSIRIS<sup>®</sup> property explorer, PASS online web resource and MOLINSPIRATION<sup>®</sup> software, to predict the pharmacokinetic characteristics and biological activity of glucomoringin. <b>Results & conclusion:</b> Molecular docking indicates strong binding to <i>I-1β</i> and the pharmacokinetic profile shows cytochrome P450 enzyme inhibition, prompting further research for dosing strategies. Toxicological predictions affirm safety, while bioactivity assessments demonstrate versatility in modulating essential pathways. glucomoringin's potential for Alzheimer's treatment, emphasizing the need for additional empirical research.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2340280"},"PeriodicalIF":2.4,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137837/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141179377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-15eCollection Date: 2024-01-01DOI: 10.2144/fsoa-2023-0298
Abdikarin Ahmed Mohamed, Yavuz Bastug, Cem Senol, Mohamed Muktar Kassim, Abdisalam Abdullahi Yusuf, Abdikarim Hussein Mohamed
Aim: Studies concerning epidemiology and drug susceptibility patterns of pediatric urinary tract infection in developing countries are scarce. This study aimed to evaluate the antimicrobial resistance pattern and uropathogens distribution in children. Method: Four-year retrospective study included 840 participants in all pediatric age groups whose urine had been cultured. Results: The prevalence of culture-proven pediatric UTIs was 17.6% (148/840). Escherichia coli was the most common pathogen isolated from the cultures, accounting for (48%, 71/148), followed by Klebsiella pneumoniae (16.2%, 24/148). About 27% of the pathogens had a multidrug-resistant (MDR) pattern. A resistance rate against nitrofurantoin at 24.6%, fosfomycin at 15.2% and trimethoprim-sulfamethoxazole (SMX-TMP) at 79.7% was noted. Conclusion:E. coli and Klebsiella pneumoniae were the most common pathogens isolated.
{"title":"Antimicrobial resistance pattern and uropathogens distribution in children visiting a referral hospital in Mogadishu.","authors":"Abdikarin Ahmed Mohamed, Yavuz Bastug, Cem Senol, Mohamed Muktar Kassim, Abdisalam Abdullahi Yusuf, Abdikarim Hussein Mohamed","doi":"10.2144/fsoa-2023-0298","DOIUrl":"10.2144/fsoa-2023-0298","url":null,"abstract":"<p><p><b>Aim:</b> Studies concerning epidemiology and drug susceptibility patterns of pediatric urinary tract infection in developing countries are scarce. This study aimed to evaluate the antimicrobial resistance pattern and uropathogens distribution in children. <b>Method:</b> Four-year retrospective study included 840 participants in all pediatric age groups whose urine had been cultured. <b>Results:</b> The prevalence of culture-proven pediatric UTIs was 17.6% (148/840). <i>Escherichia coli</i> was the most common pathogen isolated from the cultures, accounting for (48%, 71/148), followed by <i>Klebsiella pneumoniae</i> (16.2%, 24/148). About 27% of the pathogens had a multidrug-resistant (MDR) pattern. A resistance rate against nitrofurantoin at 24.6%, fosfomycin at 15.2% and trimethoprim-sulfamethoxazole (SMX-TMP) at 79.7% was noted. <b>Conclusion:</b> <i>E. coli</i> and <i>Klebsiella pneumoniae</i> were the most common pathogens isolated.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO978"},"PeriodicalIF":2.5,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141179419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-15eCollection Date: 2024-01-01DOI: 10.2144/fsoa-2023-0101
Naser Yamani, Syed Hasham Ali, Mahnoor Sadiq, Afeera B Ahmed, Kapil D Bhojwani, Vivek P Lohana, Saba Fatmah, Shazra Khalid, Hammad R Shamsi, Batool Zehra, Kaneez Fatima, Zulfiqar Q Baloch
Aim: This meta-analysis aims to shed light on any primacy the trans-carotid (TC-TAVR) access may have over the trans-femoral access (TF-TAVR) for those undergoing transcatheter aortic valve replacement (TAVR). Methods: PubMed/MEDLINE and Cochrane Library were searched, from inception to March 2023 retrieving seven adjusted studies with a total of 6609 patients, of which 5048 underwent TF-TAVR while 1561 underwent TC-TAVR. Results: No divergence in risk of mortality, major bleeding or stroke/transient ischemic attack in TC-TAVR when compared with TF-TAVR was found. In TC-TAVR, the risk of vascular complications was low (OR: 0.51, 95% CI: 0.32-0.83, p = 0.003) as compared with TF-TAVR. Conclusion: As of this analysis, the viability of TC-TAVR as first alternative to TF-TAVR is plausible.
{"title":"Trans-femoral versus trans-carotid access for transcatheter aortic valve replacement: an updated systematic review and meta-analysis.","authors":"Naser Yamani, Syed Hasham Ali, Mahnoor Sadiq, Afeera B Ahmed, Kapil D Bhojwani, Vivek P Lohana, Saba Fatmah, Shazra Khalid, Hammad R Shamsi, Batool Zehra, Kaneez Fatima, Zulfiqar Q Baloch","doi":"10.2144/fsoa-2023-0101","DOIUrl":"10.2144/fsoa-2023-0101","url":null,"abstract":"<p><p><b>Aim:</b> This meta-analysis aims to shed light on any primacy the <i>trans</i>-carotid (TC-TAVR) access may have over the <i>trans</i>-femoral access (TF-TAVR) for those undergoing transcatheter aortic valve replacement (TAVR). <b>Methods:</b> PubMed/MEDLINE and Cochrane Library were searched, from inception to March 2023 retrieving seven adjusted studies with a total of 6609 patients, of which 5048 underwent TF-TAVR while 1561 underwent TC-TAVR. <b>Results:</b> No divergence in risk of mortality, major bleeding or stroke/transient ischemic attack in TC-TAVR when compared with TF-TAVR was found. In TC-TAVR, the risk of vascular complications was low (OR: 0.51, 95% CI: 0.32-0.83, p = 0.003) as compared with TF-TAVR. <b>Conclusion:</b> As of this analysis, the viability of TC-TAVR as first alternative to TF-TAVR is plausible.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO930"},"PeriodicalIF":2.5,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137775/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141181795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-15eCollection Date: 2024-01-01DOI: 10.2144/fsoa-2023-0076
Georges Yared, Jihad Al Hasssan, Charlotte Al Hajjar, Kariman Ghazal
Background: Quantum leadership in postpartum hemorrhage (PPH) simulation training remains underexplored. Quantum leaders excel in PPH's chaotic settings, differing from traditional leaders. Aiming: To assess the impact of simulation training on quantum leadership skills in maternity teams. Research design: A quasi-experimental approach. Sample: 60 maternity professionals from Rafik Hariri University Hospital, Lebanon. Tools: Structured interviews, observational checklists and a leadership skills scale. Results: Most participants had limited PPH simulation experience and showed an initial low proficiency. Significant improvements were evident, post training. Conclusion: Simulation training enhances quantum leadership in PPH management among maternity professionals.
{"title":"Post-partum hemorrhage: a multidisciplinary approach to 'the golden hour' quantum leadership and communication.","authors":"Georges Yared, Jihad Al Hasssan, Charlotte Al Hajjar, Kariman Ghazal","doi":"10.2144/fsoa-2023-0076","DOIUrl":"10.2144/fsoa-2023-0076","url":null,"abstract":"<p><p><b>Background:</b> Quantum leadership in postpartum hemorrhage (PPH) simulation training remains underexplored. Quantum leaders excel in PPH's chaotic settings, differing from traditional leaders. <b>Aiming:</b> To assess the impact of simulation training on quantum leadership skills in maternity teams. <b>Research design:</b> A quasi-experimental approach. <b>Sample:</b> 60 maternity professionals from Rafik Hariri University Hospital, Lebanon. <b>Tools:</b> Structured interviews, observational checklists and a leadership skills scale. <b>Results:</b> Most participants had limited PPH simulation experience and showed an initial low proficiency. Significant improvements were evident, post training. <b>Conclusion:</b> Simulation training enhances quantum leadership in PPH management among maternity professionals.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO905"},"PeriodicalIF":2.5,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11140635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141199589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-15eCollection Date: 2024-01-01DOI: 10.2144/fsoa-2023-0245
Rukaiah Fatma Begum, Sumithra Mohan
Aim: This study seeks to explore the possibility of using vitamin E to alleviate the symptoms of polycystic ovarian syndrome (PCOS). Methods: Various computational methods were employed, including network pharmacology utilizing a compound-target-pathway approach, Swiss ADME, OSIRIS® property explorer, pkCSM, PASS online web resource and MOLINSPIRATION® software. In addition, in silico analysis of vitamin E was performed with ten receptors. Results & discussion: Our findings highlight the diverse potential of vitamin E in alleviating PCOS. The observed influence on hormones is in line with existing PCOS theories regarding cyst development, further enhancing the therapeutic promise of vitamin E. Conclusion: In conclusion, our computational analysis indicates that vitamin E shows potential as a therapeutic agent for alleviating PCOS in adolescents.
目的:本研究旨在探讨使用维生素 E 缓解多囊卵巢综合征(PCOS)症状的可能性。研究方法:采用了多种计算方法,包括利用化合物-目标-途径方法的网络药理学、Swiss ADME、OSIRIS® Property explorer、pkCSM、PASS 在线网络资源和 MOLINSPIRATION® 软件。此外,还利用十种受体对维生素 E 进行了硅学分析。结果与讨论我们的研究结果凸显了维生素 E 在缓解多囊卵巢综合症方面的多种潜力。观察到的对激素的影响与现有的多囊卵巢综合症关于囊肿发展的理论相一致,进一步增强了维生素 E 的治疗前景:总之,我们的计算分析表明,维生素 E 具有缓解青少年多囊卵巢综合症的治疗潜力。
{"title":"Systematic exploration of network pharmacology, <i>in silico</i> modeling and pharmacokinetic profiling for vitamin E in polycystic ovarian syndrome.","authors":"Rukaiah Fatma Begum, Sumithra Mohan","doi":"10.2144/fsoa-2023-0245","DOIUrl":"10.2144/fsoa-2023-0245","url":null,"abstract":"<p><p><b>Aim:</b> This study seeks to explore the possibility of using vitamin E to alleviate the symptoms of polycystic ovarian syndrome (PCOS). <b>Methods:</b> Various computational methods were employed, including network pharmacology utilizing a compound-target-pathway approach, Swiss ADME, OSIRIS<sup>®</sup> property explorer, pkCSM, PASS online web resource and MOLINSPIRATION<sup>®</sup> software. In addition, <i>in silico</i> analysis of vitamin E was performed with ten receptors. <b>Results & discussion:</b> Our findings highlight the diverse potential of vitamin E in alleviating PCOS. The observed influence on hormones is in line with existing PCOS theories regarding cyst development, further enhancing the therapeutic promise of vitamin E. <b>Conclusion:</b> In conclusion, our computational analysis indicates that vitamin E shows potential as a therapeutic agent for alleviating PCOS in adolescents.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO952"},"PeriodicalIF":2.4,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137767/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141179447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aim: Recently, the emergency of multidrug-resistant organisms (MDRO) has complicated the management of bacterial infections (BI) in cirrhosis. We aimed to assess their clinical impact on patients with decompensated cirrhosis. Methods: A retrospective study included consecutive cirrhotic patients hospitalized for acute decompensation (AD) between January 2010 and December 2019. Results: A total of 518 AD admissions in 219 patients were included, with 260 BI episodes (50.2%). MDRO prevalence was 38.2% of the total isolates. Recent antibiotic use (OR = 4.91), nosocomial infection (OR = 2.95), and healthcare-associated infection (OR = 3.45) were their main risk factors. MDROs were associated with empiric treatment failure (OR = 23.42), a higher prevalence of sepsis (OR = 4.93), ACLF (OR = 3.42) and mortality. Conclusion: The clinical impact of MDROs was pejorative, with an increased risk of empiric treatment failure, organ failure and death.
{"title":"Clinical impact of multidrug-resistant bacterial infections in patients with cirrhosis.","authors":"Nouha Trad, Ghanem Mohamed, Sondes Bizid, Hatem Ben Abdallah, Riadh Bouali, Mohamed Nabil Abdelli","doi":"10.2144/fsoa-2023-0160","DOIUrl":"10.2144/fsoa-2023-0160","url":null,"abstract":"<p><p><b>Aim:</b> Recently, the emergency of multidrug-resistant organisms (MDRO) has complicated the management of bacterial infections (BI) in cirrhosis. We aimed to assess their clinical impact on patients with decompensated cirrhosis. <b>Methods:</b> A retrospective study included consecutive cirrhotic patients hospitalized for acute decompensation (AD) between January 2010 and December 2019. <b>Results:</b> A total of 518 AD admissions in 219 patients were included, with 260 BI episodes (50.2%). MDRO prevalence was 38.2% of the total isolates. Recent antibiotic use (OR = 4.91), nosocomial infection (OR = 2.95), and healthcare-associated infection (OR = 3.45) were their main risk factors. MDROs were associated with empiric treatment failure (OR = 23.42), a higher prevalence of sepsis (OR = 4.93), ACLF (OR = 3.42) and mortality. <b>Conclusion:</b> The clinical impact of MDROs was pejorative, with an increased risk of empiric treatment failure, organ failure and death.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO945"},"PeriodicalIF":2.5,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11131343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-14eCollection Date: 2024-01-01DOI: 10.2144/fsoa-2023-0203
Ramzi Tababi, Soumaya Mrabet, Imen Akkari, Raida Harbi, Elhem Ben Jazia
Aim: Evaluating prognostic scores' utility in predicting ursodeoxycholic acid (UDCA) biochemical response (BR) and long-term liver-related complications in primary biliary cholangitis (PBC) patients. Patients & methods: This retrospective single-center study included 50 predominantly female PBC patients (median age: 56) on UDCA treatment. BR was defined by Paris II criteria. Liver-related complications during a median 76-month follow-up were assessed. APRI, ALBI, Mayo, GLOBE and UK-PBC scores were calculated. Results: 64% achieved BR, while 40% experienced liver-related complications. All scores showed good BR prediction (concordance statistics: 0.76-0.94) and excellent negative predictive values for 5-year liver complications (concordance statistics: 0.73-0.89). Conclusion: Implementing these scores in clinical practice is encouraged due to their effectiveness in predicting BR- and liver-related events.
{"title":"Prognostic scores in primary biliary cholangitis.","authors":"Ramzi Tababi, Soumaya Mrabet, Imen Akkari, Raida Harbi, Elhem Ben Jazia","doi":"10.2144/fsoa-2023-0203","DOIUrl":"10.2144/fsoa-2023-0203","url":null,"abstract":"<p><p><b>Aim:</b> Evaluating prognostic scores' utility in predicting ursodeoxycholic acid (UDCA) biochemical response (BR) and long-term liver-related complications in primary biliary cholangitis (PBC) patients. <b>Patients & methods:</b> This retrospective single-center study included 50 predominantly female PBC patients (median age: 56) on UDCA treatment. BR was defined by Paris II criteria. Liver-related complications during a median 76-month follow-up were assessed. APRI, ALBI, Mayo, GLOBE and UK-PBC scores were calculated. <b>Results:</b> 64% achieved BR, while 40% experienced liver-related complications. All scores showed good BR prediction (concordance statistics: 0.76-0.94) and excellent negative predictive values for 5-year liver complications (concordance statistics: 0.73-0.89). <b>Conclusion:</b> Implementing these scores in clinical practice is encouraged due to their effectiveness in predicting BR- and liver-related events.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO975"},"PeriodicalIF":2.5,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137771/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141179432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-14eCollection Date: 2024-01-01DOI: 10.2144/fsoa-2023-0180
Mouna Medhioub, Amal Khsiba, Moufida Mahmoudi, Asma Ben Mohamed, Manel Yakoubi, Emna Haouet, Lamine Hamzaoui
Thyroid storm is a life-threatening condition associated with multiorgan dysfunction and decompensation. We report the case of a 41-year-old woman having Graves' disease presented with thyroid storm complicated with liver dysfunction and portal hypertension in the absence of congestive heart failure or known liver disease. After successful therapeutic management, all biological, clinical and morphological abnormalities regressed.
{"title":"Thyroid storm-induced acute liver dysfunction and portal hypertension in a patient with Graves' disease: a case report.","authors":"Mouna Medhioub, Amal Khsiba, Moufida Mahmoudi, Asma Ben Mohamed, Manel Yakoubi, Emna Haouet, Lamine Hamzaoui","doi":"10.2144/fsoa-2023-0180","DOIUrl":"10.2144/fsoa-2023-0180","url":null,"abstract":"<p><p>Thyroid storm is a life-threatening condition associated with multiorgan dysfunction and decompensation. We report the case of a 41-year-old woman having Graves' disease presented with thyroid storm complicated with liver dysfunction and portal hypertension in the absence of congestive heart failure or known liver disease. After successful therapeutic management, all biological, clinical and morphological abnormalities regressed.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO929"},"PeriodicalIF":2.5,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141181794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aim: This systematic review aims to consolidate findings from current clinical trials that compare the effectiveness of insulin infusion at 0.05 IU/kg/h versus 0.1 IU/kg/h in managing pediatric diabetic ketoacidosis. Methods: We searched several databases, including PubMed, Embase, Scopus, Cochrane Central and Web of Science. Our primary outcomes were time to reach blood glucose ≤250 mg/dl and time to resolution of acidosis. Secondary outcomes included rate of blood glucose decrease per hour, incidence of hypoglycemia, hypokalemia, treatment failure, and cerebral edema. Results & conclusion: The present study establishes that a low insulin dose exhibits comparable efficacy to the standard dosage for managing pediatric patients suffering from diabetic ketoacidosis, with a lower incidence of complications.
目的:本系统性综述旨在整合当前临床试验的研究结果,这些临床试验比较了胰岛素输注量为 0.05 IU/kg/h 与 0.1 IU/kg/h 对控制小儿糖尿病酮症酸中毒的有效性。方法:我们检索了多个数据库,包括 PubMed、Embase、Scopus、Cochrane Central 和 Web of Science。我们的主要结果是血糖≤250 mg/dl 的时间和酸中毒缓解的时间。次要结果包括每小时血糖下降率、低血糖发生率、低钾血症、治疗失败和脑水肿。结果和结论:本研究证实,低剂量胰岛素治疗糖尿病酮症酸中毒儿科患者的疗效与标准剂量相当,且并发症发生率较低。
{"title":"Low dose insulin infusion versus the standard dose in children with diabetic ketoacidosis: a meta-analysis.","authors":"Mohamed Mohamed Belal, Basma Badrawy Khalefa, Eslam Mohammed Rabea, Mazen Negmeldin Aly Yassin, Mohamed Nabih Bashir, Malak Mohamed Abd El-Hameed, Omar Elkoumi, Saad Mohamed Saad, Loubna Mohamed Saad, Mohamed Hamouda Elkasaby","doi":"10.2144/fsoa-2023-0137","DOIUrl":"10.2144/fsoa-2023-0137","url":null,"abstract":"<p><p><b>Aim:</b> This systematic review aims to consolidate findings from current clinical trials that compare the effectiveness of insulin infusion at 0.05 IU/kg/h versus 0.1 IU/kg/h in managing pediatric diabetic ketoacidosis. <b>Methods:</b> We searched several databases, including PubMed, Embase, Scopus, Cochrane Central and Web of Science. Our primary outcomes were time to reach blood glucose ≤250 mg/dl and time to resolution of acidosis. Secondary outcomes included rate of blood glucose decrease per hour, incidence of hypoglycemia, hypokalemia, treatment failure, and cerebral edema. <b>Results & conclusion:</b> The present study establishes that a low insulin dose exhibits comparable efficacy to the standard dosage for managing pediatric patients suffering from diabetic ketoacidosis, with a lower incidence of complications.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO956"},"PeriodicalIF":2.5,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11140676/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141199588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-14eCollection Date: 2024-01-01DOI: 10.2144/fsoa-2023-0229
Salene Mw Jones, Jean Yi, Nora B Henrikson, Laura Panattoni, Veena Shankaran
Aim: This qualitative study refined a conceptual model of financial hardship and developed measures corresponding to model constructs. Methods: Eighteen women with breast cancer recruited through a comprehensive cancer center completed interviews. A qualitative framework analysis was conducted of the interviews. Results: Participants experienced varying levels of financial hardship. Protective factors included good health insurance, work accommodations and social support. Participants worried about cancer care costs and employment. Programs for alleviating financial hardship had high administrative burdens. Four preliminary financial hardship measures were developed: coping, impacts, depression and worry. Conclusion: Reducing administrative barriers to benefits could reduce financial hardship after cancer. More research is needed on the effects of out-of-network/formulary care and denials of coverage and to validate the measures.
{"title":"Financial hardship after cancer: revision of a conceptual model and development of patient-reported outcome measures.","authors":"Salene Mw Jones, Jean Yi, Nora B Henrikson, Laura Panattoni, Veena Shankaran","doi":"10.2144/fsoa-2023-0229","DOIUrl":"10.2144/fsoa-2023-0229","url":null,"abstract":"<p><p><b>Aim:</b> This qualitative study refined a conceptual model of financial hardship and developed measures corresponding to model constructs. <b>Methods:</b> Eighteen women with breast cancer recruited through a comprehensive cancer center completed interviews. A qualitative framework analysis was conducted of the interviews. <b>Results:</b> Participants experienced varying levels of financial hardship. Protective factors included good health insurance, work accommodations and social support. Participants worried about cancer care costs and employment. Programs for alleviating financial hardship had high administrative burdens. Four preliminary financial hardship measures were developed: coping, impacts, depression and worry. <b>Conclusion:</b> Reducing administrative barriers to benefits could reduce financial hardship after cancer. More research is needed on the effects of out-of-network/formulary care and denials of coverage and to validate the measures.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO983"},"PeriodicalIF":2.5,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11140643/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141199587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}